Acta Neuropathol, 2019 · DOI: 10.1007/s00401-019-01992-3 · Published: May 1, 2019
Macrophages, derived from infiltrating monocytes, play a crucial role in spinal cord injury (SCI) by mediating inflammation, cell proliferation, tissue remodeling, and differentiation. These macrophages exhibit distinct functions from resident microglia and can exert both harmful and beneficial effects following SCI, largely influenced by environmental cues that dictate their polarization state. Different macrophage origins, such as the spleen, bone marrow, and local self-renewal, might also influence their fate and function, contributing to the complex pathobiology of SCI.
Understanding the distinct roles of macrophages from different origins (spleen, bone marrow, local self-renewal) could lead to targeted therapies that promote beneficial macrophage populations while reducing harmful ones.
Strategies aimed at shifting macrophage polarization from a pro-inflammatory (M1-like) to an anti-inflammatory (M2-like) phenotype may improve tissue repair and functional recovery after SCI.
Given the characterization of SCI macrophages as lipid-laden foam cells, targeting lipid catabolic pathways could reduce inflammation and improve outcomes, potentially drawing from therapeutic strategies used in atherosclerosis.